Abstract
Depression, anxiety, and other psychological issues are more prevalent among patients with chronic diseases such as chronic kidney disease (CKD) compared to the general population and patients in primary care settings. Nearly one out of four or five patients with kidney disease experiences a major depressive disorder (MDD), which is greater than the proportion with depression reported for other chronic diseases, such as diabetes mellitus, coronary artery disease, or congestive heart failure. It is well established that the presence of either high scores on depressive symptom severity scales or a clinical diagnosis of MDD is associated with increased morbidity and mortality among patients with CKD or those treated with maintenance dialysis. Therefore, recognizing depressive symptoms, diagnosing MDD, and excluding other conditions such as anxiety, pain, somatic symptoms of uremia, dementia, and delirium are very important to develop appropriate management strategies for such patients. Validated tools can be used to screen for depressive symptoms, and a clinical diagnosis of depression should be confirmed in those who screen positive either by using a structured clinician-administered interview or by referral to mental health, based on complexity of the presentation and presence of comorbid psychiatric illnesses, such as bipolar disorders. Risk for suicide should be ascertained and triaged appropriately. Various pharmacological and non-pharmacological interventions can be applied to treat MDD in patients with CKD, but data on safety and efficacy are limited. If antidepressant medications are considered, they should be initiated at a low dose and titrated up based on frequent monitoring to ensure tolerability and response to treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54:741–52.
Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84:179–91.
Hedayati SS, Bosworth H, Briley L, et al. Death or hospitalization of patients on chronic hemodialysis is associated with a physician-based diagnosis of depression. Kidney Int. 2008;74:930–6.
Lopes AA, Bragg J, Young E, Goodkin D, Mapes D, Combe C, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int. 2002;62:199–207.
Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Alleyne S, Cruz I, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int. 2000;57:2093–8.
Hedayati SS, Minhajuddin AT, Afshar M, Toto RD, Trivedi MH, Rush AJ. Association between major depressive episodes in patients with chronic kidney disease and initiation of dialysis, hospitalization, or death. JAMA. 2010;303:1946–53.
Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol. 2007;2:1332–42.
Cohen SD, Patel SS, Khetpal P, Peterson RA, Kimmel PL. Pain, sleep disturbance, and quality of life in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2007;2:919–25.
Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Boyle DH, Umana WO, et al. Psychologic functioning, quality of life, and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol. 1996;7:2152–9.
Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81(3):247–55.
Hedayati SS, Minhajuddin AT, Toto RD, Morris DW, Rush AJ. Validation of depression screening scales in patients with CKD. Am J Kidney Dis. 2009;54:433–9.
Watnick S, Wang PL, Demadura T, Ganzini L. Validation of 2 depression screening tools in dialysis patients. Am J Kidney Dis. 2005;46:919–24.
Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int. 2011;79:14–22.
Nagler EV, Webster AC, Vanholder R, Zoccali C. Antidepressants for depression in stage 3-5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736–45.
The FHN Trial Group. In-Center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–300.
Acknowledgments
Work from Dr. Hedayati’s laboratory was supported by grant number R01DK085512 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and VA MERIT grant (CX000217-01). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK, the National Institutes of Health, or the Department of Veterans Affairs.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jain, N., Hedayati, S.S. (2014). Depression and Other Psychological Issues in Chronic Kidney Disease. In: Arici, M. (eds) Management of Chronic Kidney Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54637-2_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-54637-2_23
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54636-5
Online ISBN: 978-3-642-54637-2
eBook Packages: MedicineMedicine (R0)